Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
05. December 2025
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8713
Articles 1 - 20 / 174244
Challenges of data quality for the management of prostate cancer in Tanzania: A hurdle towards improving the quality of service.
PLOS Glob Public Health
Nyongole O, Munishi C, Kimu N, Sangeda RZ, Mseti M, Lugina E, Kiwara F, Sirili N, Chacha F, Nicholaus B, Frumence G, Simba D, Urassa D, Sunguya B.
PMID: 41343577 [PubMed]
Identification and validation of palmitoylation-related signature genes based on machine learning for prostate cancer.
PLoS One
Wo Q, Shou J, Shi J, Shi L, Yang Y, Wang Y, Xie L.
PMID: 41343534 [PubMed - indexed for MEDLINE]
Improving Prostate MRI: Lessons Learned from the American College of Radiology's Prostate MR Image Quality Improvement Collaborative.
Radiographics
Purysko AS, Garcia-Tomkins K, Zacharias-Andrews K, Bittencourt LK, Giganti F, Turkbey B, Costa D, Gupta RT, Bhargavan-Chatfield M, Larson DB, Prostate MR Image Quality Improvement Collaborative, Prostate MR Image Quality Improvement Collaborative members.
PMID: 41343296 [PubMed - indexed for MEDLINE]
Framework for Race-Specific Prostate Cancer Detection Using Machine Learning Through Gene Expression Data: Feature Selection Optimization Approach.
JMIR Bioinform Biotechnol
Agustriawan D, Mulia A, Overbeek MV, Kurniawan V, Syechlo J, Widjaja M, Ahmad MI.
PMID: 41342168 [PubMed]
Risk Signals of Antibody-Drug Conjugates in Bladder Cancer: A Real-World FAERS Study.
Clin Epidemiol
Liu J, Li G, Yang J, Sun B, Guo S.
PMID: 41341429 [PubMed]
Case Report: Clinical pathological characteristics, diagnosis, and treatment analysis of eosinophilic solid and cystic renal cell carcinoma: experience from a five-case series.
Front Oncol
Zi GR, Feng RL, Guo X, Zhang DJ, He DL, Ke CX.
PMID: 41341398 [PubMed]
Prospective trial on focal treatment with hemigland brachytherapy in low-risk prostate cancer: A negative study.
J Contemp Brachytherapy
Gutiérrez C, Villafranca E, Ferrer M, Sola A, Slocker A, Ventura M, Visus I, Pino F, Barrado M, Illas M, Najjari D, Fuentemilla N, Araguás P, Pellejero S, Garin O.
PMID: 41340828 [PubMed]
A Randomised Clinical Trial Comparing Two Biopsy Templates and Follow-up Schedules for Men on Active Surveillance for Low-risk Prostate Cancer: SAMS.
Eur Urol Open Sci
Robinson D, Maljkovic J, Genell A, Carlsson S, Holmberg E, Bratt O, SAMS Trial Group.
PMID: 41340679 [PubMed]
A novel biochip-based liquid biopsy for extracellular vesicle RNA detection in prostate cancer.
Cancer Biol Ther
Diao Y, Nan A, Li R, Ding T, Li Z, Wang J, Zhu B, Li J, Yang L, Zhou L, Liu J, Hao X.
PMID: 41340217 [PubMed - indexed for MEDLINE]
Single-cell sequencing in bladder cancer: new insights from tumor cell diversity to individualized treatment strategies.
Cancer Cell Int
Liufu C, Ye S, Yin C, Zhu T, Jiang J, Wang Y, Shi B.
PMID: 41339886 [PubMed - as supplied by publisher]
Global, regional, and national burdens of bladder cancer attributable to high fasting plasma glucose from 1990 to 2021, with future forecasts to 2050: a systematic analysis for the global burden of disease study 2021.
BMC Cancer
Lan K, Zhang Y, Luo Y, Hong T, Liu X, Hu Y, Lin W, Hong X, Zhang Y.
PMID: 41339802 [PubMed - as supplied by publisher]
The association between lower urinary tract symptoms and urinary tract infections, and subsequent prostate cancer workup: a nationwide population-based case-control study.
Br J Cancer
Widding JL, Stroomberg HV, Dalton SO, Brasso K, Røder A, Larsen SB.
PMID: 41339755 [PubMed - as supplied by publisher]
Age-related survival disparities in advanced renal cell carcinoma following immune checkpoint inhibitor adoption using SEER and meta-analysis.
Sci Rep
Al-Danakh A, Jian Y, Yang L, Safi M, Zhu X, Alradhi M, Askar B, Baldi S, Chen Q, Wang S, Yang D.
PMID: 41339655 [PubMed - as supplied by publisher]
A Prostatic Extra-Gastrointestinal Stromal Tumor Treated by Surgery: A Case Report with 7-Year Follow-Up and Review of Literature.
Arch Esp Urol
Yang E, Jing S, Fan G, Fan N, Zhang Y, Zhang W, Wang Y, Sun X, Wang Z.
PMID: 41339245 [PubMed - indexed for MEDLINE]
Case Report of Rare Metastasis of Renal Cell Carcinoma to the Bladder: A New Hypothesis and Literature Review.
Arch Esp Urol
Manav AN.
PMID: 41339243 [PubMed - indexed for MEDLINE]
Effect of Nutritional-Psychological Dual-Wheel-Driven Enhanced Recovery after Surgery Nursing on the Prognosis of Patients with Bladder Cancer: A Retrospective Cohort Study.
Arch Esp Urol
Guo J, Xue J, Yu Z, Dong J, Liu M.
PMID: 41339239 [PubMed - indexed for MEDLINE]
Effect of Continuity of Care on Cancer-Related Fatigue, Self-Care Ability and Fear of Recurrence in Patients with Intravesical Chemotherapy after Transurethral Resection of Bladder Tumors.
Arch Esp Urol
Huang Z, Cai Y, Zhong H, Zhou L.
PMID: 41339235 [PubMed - indexed for MEDLINE]
Diagnostic Values of Serum Matrix Metalloproteinase-9 and Nuclear Matrix Protein 22 for Bladder Cancer.
Arch Esp Urol
Chen L, He J.
PMID: 41339233 [PubMed - indexed for MEDLINE]
Efficacy Evaluation of Multi-Slice Spiral CT in Patients with Muscle-Invasive Bladder Cancer after Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin.
Arch Esp Urol
Guo H, Zhang L, Xu F, Liu P.
PMID: 41339230 [PubMed - indexed for MEDLINE]
Metabolomics in Prostate Cancer: A Minimally Invasive Method Using Urine after Prostatic Massage to Predict Gleason Grade.
Arch Esp Urol
Panach-Navarrete J, González-Marrachelli V, Morales-Tatay JM, García-Morata F, Sales-Maicas MÁ, Monleón-Salvado D, Martínez-Jabaloyas JM.
PMID: 41339219 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 174244
Page 1 of 8713
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy